Although SREBP2/HMGCR and SREBP1 showed high expression, FASN exhibited an overtly low level in the two cell lines, indicating that SREBP1/FASN signaling is non‐activated in CRC cells without stimulation (Fig. 2J). Here, SREBF2 is linked to colorectal carcinoma.